Mack CA
No ORCID on file
· 1 paper in corpus
2026
IntroductionAldo-keto reductase 1C3 (AKR1C3) is a drug target for the treatment of various androgen‑dependent malignancies, including castration-resistant prostate cancer as well as hematological cancers. The enzyme plays a key role in the …